ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04360	Axon guidance	39/297	233/7206	2.5604832096e-14
ko05217	Basal cell carcinoma	21/297	68/7206	1.33235205478e-13
ko04550	Signaling pathways regulating pluripotency of stem cells	27/297	165/7206	5.36659252268e-10
ko04340	Hedgehog signaling pathway	15/297	58/7206	7.08949119601e-09
ko05224	Breast cancer	25/297	174/7206	3.68643558177e-08
ko04390	Hippo signaling pathway	26/297	188/7206	4.33083398115e-08
ko04330	Notch signaling pathway	14/297	62/7206	1.46486290877e-07
ko04391	Hippo signaling pathway - fly	15/297	90/7206	3.30092483164e-06
ko04950	Maturity onset diabetes of the young	8/297	29/7206	1.52522915652e-05
ko05200	Pathways in cancer	39/297	492/7206	7.96191031113e-05
ko04341	Hedgehog signaling pathway - fly	7/297	38/7206	0.000789572335406
ko00514	Other types of O-glycan biosynthesis	6/297	30/7206	0.00119732753796
ko04512	ECM-receptor interaction	10/297	79/7206	0.00140473879751
ko04310	Wnt signaling pathway	17/297	181/7206	0.00167376488502
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	5/297	26/7206	0.00370478756124
ko05034	Alcoholism	2/297	238/7206	0.00439006092531
ko05203	Viral carcinogenesis	3/297	277/7206	0.00504414534323
ko05202	Transcriptional misregulation in cancer	15/297	188/7206	0.0136734420709
ko04080	Neuroactive ligand-receptor interaction	8/297	423/7206	0.0157525402133
ko04916	Melanogenesis	12/297	142/7206	0.01636109368
ko04658	Th1 and Th2 cell differentiation	9/297	96/7206	0.0170359692596
ko05322	Systemic lupus erythematosus	1/297	151/7206	0.0216476761721
ko04514	Cell adhesion molecules (CAMs)	11/297	130/7206	0.0220434071699
ko04932	Non-alcoholic fatty liver disease (NAFLD)	2/297	182/7206	0.0353504032474
ko04141	Protein processing in endoplasmic reticulum	2/297	184/7206	0.0358201146156
ko04530	Tight junction	16/297	228/7206	0.0392962106662
ko00603	Glycosphingolipid biosynthesis - globo and isoglobo series	2/297	8/7206	0.0402142470546
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	3/297	19/7206	0.0411770893683
ko05205	Proteoglycans in cancer	18/297	271/7206	0.041573609179
ko04915	Estrogen signaling pathway	1/297	131/7206	0.0448103316326
ko05166	HTLV-I infection	19/297	292/7206	0.0485753365758
ko04921	Oxytocin signaling pathway	3/297	209/7206	0.0496223891624